Global Cardiac Resynchronization Therapy Market Size By Product (Cardiac Resynchronization Therapy Defibrillators, Cardiac Resynchronization Therapy Pacemakers), By End-User (Hospitals & Cardiac Centers, Ambulatory Surgery Centers), By Geographic Scope And Forecast

Cardiac Resynchronization Therapy Market Size And Forecast

Cardiac Resynchronization Therapy Market size was valued at USD 5.85 Billion in 2021 and is projected to reach USD 11.5 Billion by 2030, growing at a CAGR of 7.3% from 2022 to 2030.

Cognac has gained universal recognition as one of the finest spirits which are distilled from grapes. Qualities of cognac in terms of intensity, warmth, and subtlety, remain incomparable, which have strengthened its identity as a ‘symbol of the elite’. Similar to the case of champagne, cognac continues to be protected by law and remains subjected to strict production criteria. The Global Cardiac Resynchronization Therapy Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Cardiac Resynchronization Therapy Market Definition

Cardiac resynchronization therapy or biventricular pacing is a small device that sends electrical impulses to lower chambers of the heart, helping them to beat together in a more synchronized pattern. Implantable device helps to beat the heart more efficiently. Cardiac resynchronization therapy system comprises of two components, the pulse generator, or device and thin insulted wires also known as leads. There are various benefits associated with cardiac resynchronization therapy system, as it improves heart efficiency, increases blood flow and improves quality of life. CRT (cardiac resynchronization therapy) is a therapy that helps the heartbeat in the proper rhythm.

It utilizes a pacemaker to restore the heartbeat’s regular timing rhythm. CRT is a treatment in which a device is implanted in the chest to help the patient’s heart chambers squeeze (contract) more effectively. Traditionally, cardiac resynchronization therapy has been used to treat patients who have heart failure and then develop an arrhythmia. Intraventricular dyssynchrony, interventricular dyssynchrony, and atrioventricular dyssynchrony are all treated using cardiac resynchronization treatment. A cardiac resynchronization treatment pacemaker and a cardiac resynchronization therapy defibrillator are two types of cardiac resynchronization therapy devices.

The cardiac resynchronization therapy system gadget operates by providing electrical signals to the heart muscle to resynchronize the contractions of the heart ventricles. Pacemaker technology has progressed into cardiac resynchronization treatment devices. This treatment has dramatically reduced the number of people who die as a result of heart failure. The use of cardiac resynchronization therapy for the treatment of heart failure patients has resulted in a reduction in the number of deaths caused by sudden cardiac arrest in these individuals.

Global Cardiac Resynchronization Therapy Market Overview

In the section mainly encompasses the fundamental dynamics of the market which include drivers, restraints, opportunities and challenges faced by the industry. Drivers and restraints are intrinsic factors whereas opportunities and challenges are extrinsic factors of the market. The rising incidence of cardiovascular diseases globally is expected to boost the growth of the global Cardiac Resynchronization Therapy Market. Moreover, an increasing number of product launches is expected to fuel the global market. For instance, in 2017, Resonate Cardiac Resynchronization Therapy defibrillator (CRT-D) systems were launched by Boston Scientific in Europe.

On the other side, lack of skilled personnel and limitation of the use of Cardiac Resynchronization Therapy in pediatric patients are the factors that might restrict the market growth. Market Research narrows down the available data using primary sources to validate the data and use it in compiling a full-fledged market research study. The report contains a quantitative and qualitative estimation of market elements that interest the client. The “Global Cardiac Resynchronization Therapy Market” is mainly bifurcated into sub-segments which can provide classified data regarding the latest trends in the market.

An increase in the cases of heart attacks among the population, an increase in the investment in Cardiac Resynchronization Therapy, an increase in the incidence of target diseases, and an increase in the healthcare expenditure are among the major factors driving the Cardiac Resynchronization Therapy Market, among others. Furthermore, in the anticipated period, technological developments and modernization in healthcare devices, as well as growth in emerging regions with an expanding senior population base, will generate new opportunities for the Cardiac Resynchronization Therapy Market.

Global Cardiac Resynchronization Therapy Market Segmentation Analysis

The Global Cardiac Resynchronization Therapy Market is segmented on the basis of Product, End-User, and Geography.

Cardiac Resynchronization Therapy Market, By Product

• Cardiac Resynchronization Therapy Defibrillators• Cardiac Resynchronization Therapy Pacemakers

Based on Product, the market is segmented into Cardiac Resynchronization Therapy Defibrillators and Cardiac Resynchronization Therapy Pacemakers. the global market is segmented into Cardiac Resynchronization Therapy Defibrillators (CRT-Ds) and Cardiac Resynchronization Therapy Pacemakers (CRT-Ps). The CRT-Ds segment accounted for the largest share of the market in 2018. This is majorly attributed to the increasing acceptance of CRT-Ds over pacemakers and the launch of technologically advanced devices. Furthermore, growth in this market segment is largely driven by the increasing incidence of target diseases.

Cardiac Resynchronization Therapy Market, By End-User

• Hospitals & Cardiac Centers• Ambulatory Surgery Centers

Based on End-User, the market is segmented into Hospitals & Cardiac Centers, and Ambulatory Surgery Centers. Hospitals & cardiac centers accounted for the largest share of the market in 2018. The increasing prevalence of CVD, rising number of surgical procedures performed, favorable reimbursement scenario, and the increasing number of critical care and intensive care units are some of the key factors driving the growth of the hospitals & cardiac centers segment.

Cardiac Resynchronization Therapy Market, By Geography

• North America• Europe• Asia Pacific• Rest of the World

On the basis of Regional Analysis, the Global Cardiac Resynchronization Therapy Market is classified into North America, Europe, Asia Pacific, and Rest of the world. The Asia Pacific region is projected to register the highest growth rate in the global market during the forecast period. Favorable reimbursement scenario in Japan, the rising geriatric population in China, rising incidence of CVDs, improving healthcare infrastructure, growing middle-class population, and rising disposable income levels in India are some of the key factors driving the growth of the Cardiac Resynchronization Therapy market in the Asia Pacific.

Key Players

The “Global Cardiac Resynchronization Therapy Market ” study report will provide a valuable insight with an emphasis on the global Market . The major players in the Market are Medtronic, PLC, Abbott Laboratories, Lepu Medical Technology Co., Ltd., Boston Scientific Corporation, Biotronik, Medico S.P.A., Shree Pacetronix Ltd., and Microport Scientific Corporation.

Our market analysis also entails a section solely dedicated for such major players wherein our analysts provide an insight to the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share and market ranking analysis of the above-mentioned players globally.

Key Developments

• In 2017, The company’s quadripolar Cardiac Resynchronization Therapy pacemakers (CRT-Ps), which improve therapy delivery for patients with heart failure, got FDA approval in the United States.

Report Scope

Top Trending Reports

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post-sales analyst support

Customization of the Report

• In case of any please connect with our sales team, who will ensure that your requirements are met.